Lassa Virus Reagents

Item No. Antibody Designation Clone No. Applications
 Ab00393G  Lassa virus glycoprotein subunit 1   39.3G IFA, WB, ELISA
 Ab00099F  Lassa virus glycoprotein subunit 1  9.9F IFA, WB, ELISA
 Ab00216G  Lassa virus glycoprotein subunit 1 21.6G IFA, WB, ELISA
 Ab00374E  Lassa virus glycoprotein subunit 1  37.4E IFA, WB, ELISA
 Ab00312D  Lassa virus glycoprotein subunit 1  3.12D IFA, WB, ELISA, IP
 Ab00024F  Lassa virus glycoprotein subunit 1  2.4F IFA, WB, ELISA, IP
 Ab00033B  Lassa virus glycoprotein subunit 1  3.3B IFA, ELISA, IP
 Ab00056H  Lassa virus glycoprotein subunit 1  5.6H IFA, WB, ELISA, IP
 Ab00246C  Lassa virus glycoprotein subunit 2  24.6C IFA, WB, ELISA, IP
 Ab00225D  Lassa virus glycoprotein subunit 2  22.5D IFA, ELISA, IP
 Ab00084F  Lassa virus glycoprotein subunit 2  8.4F IFA, WB, ELISA, IP
 Ab00041F  Lassa virus glycoprotein subunit 2  4.1F IFA, WB, ELISA, IP
 Ab00134E  Lassa virus glycoprotein subunit 2  13.4E IFA, ELISA, IP
 Ab00139H  Lassa virus glycoprotein subunit 2  13.9H IFA, ELISA
 Ab00036H  Lassa virus glycoprotein subunit 2  3.6H IFA, WB, ELISA, IP
 Ab00088B  Lassa virus glycoprotein subunit 2  8.8B IFA, WB, ELISA, IP
 Ab02510C  Lassa virus glycoprotein complex  25.10C IFA, ELISA, IP, VN
 Ab00361F  Lassa virus glycoprotein complex  36.1F IFA, ELISA, IP, VN
 LASVLP-II-001  LASVirus – Like Particles  lineage II WB
 LASVLP-III-002  LASVirus – Like Particles  lineage III WB
 LASVLP-IV-003  LASVirus – Like Particles  lineage IV WB
 Ab03411C  Lassa virus nucleoprotein  34.11C ELISA
 Ab00338A  Lassa virus nucleoprotein  33.8A ELISA

  Ordering process:

1. Please complete the proposal request for intended use of the reagent. Upon approval
we will request execution of a Material Transfer Agreement
2. Two-way execution of a Material Transfer Agreement
3. Ordering and shipment of the reagent

Disclaimer: For Research Use only.
References:
1. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, et al. Nat Commun. 2016 May 10;7:11544. doi: 10.1038/ncomms11544.
PMID: 27161536
2. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, et al. Cell. 2015 Aug 13;162(4):738-50. doi: 10.1016/j.cell.2015.07.020.
PMID: 26276630